Font Size




Menu Style

In Brief
  1. ISIRV Journal: For the last 5 years, another year-on-year increase - IRV Journal impact factor now 3.288
  2. Tocilizumab and Sarilumab are to be used in severe COVID patients in the UK - read more



  • Discounted isirv conference rates
  • Opportunities to network and connect with world experts in the field of respiratory virus diseases
Member Login


 SAVE THE DATE  RSV2022 Symposium                      29 Sept - 2 Oct 2022                                              
RSV 2022 logo details

Given the ongoing COVID-19 restrictions, the RSV2020 conference originally planned for September 2020 has been postponed until 2022.

RSV2022 will be hosted at the ICC Waterfront, an award-winning venue in Belfast, N.Ireland.


In the meantime, the RSV Webinar Series, held February 2021, provided research updates to the RSV Community. Webinar recordings can be accessed via the RSV Webinar Programme - key topics below:


  1 February 2021 -  Epidemiology and Spectrum of RSV Disease

                                  Keynote: Prof Harish Nair

  8 February 2021 -  RSV Molecular Biology 

                                  Keynote: Prof Carolina Lopez

 15 February 2021 - RSV Pathogenesis and Immunity 

                                  Keynote: Prof Peter Openshaw

  22 February 2021 - RSV Vaccines and Therapies  

                                  Keynote: Dr Barney S. Graham

  Visit the RSV Webinar Series Poster Gallery  

OPTIONS X Programme
OPTIONS X - Singapore

The 10th edition of the Options for the Control of Influenza conference in Singapore ended on 1 September 2019.

The 11th meeting in the series, OPTIONS XI, will be held in Milan, Italy, August 2022.

Attendance Certificates can be requested from


  OPTIONS X Programme  
Global Influenza Update

An Influenza update from the WHO can be found here.

Influenza Vaccine

The recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season can be found here.

Zoonotic Influenza

Antigenic and genetic characteristics of zoonotic influenza viruses and candidate vaccine viruses developed for potential use in human vaccines is here.


Information and links to other sources of information on this evolving situation is available in the news section.

ISIRV Awards: The Geoffrey Schild Award 2020

We are delighted to announce the winners of this award:


Dr Kirsty Short, School of Chemistry and Molecular Biosciences, The University of Queensland, Australia.

Dr Raffael Nachbagauer, Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York, USA.


This prestigious award is for outstanding early career investigators in the field of respiratory viruses.

Both Drs Short and Nachbagauer will be invited to deliver a keynote lecture at an appropriate isirv meeting, but in the interim, they have kindly agreed to deliver a webinar based on their research (further details to be announced)


New ISIRV Special Interest Group announced - International Respiratory Syncytial Virus Society

In mid-2017, the International Respiratory Syncytial Virus Society (IRSVS) became a special interest group of isirv. The IRSVS is a global independent group of RSV professionals, with members from all continents working on all research fronts. The IRSVS’s goal is to ensure that there is a succession of venues to share scientific information and accelerate the development of strategies to reduce the impact of RSV infection. Read more...

Immunological Assays and Correlates of Protection for Next Generation Influenza Vaccines: 31 March - 2 April 2019, Siena, Italy

This conference addressed new immunological assays and immune correlates of protection needed to estimate the immunogenicity and protective efficacy of next generation influenza vaccines currently being developed.Visit the website  

2nd Epidemiology meeting: Incidence, Severity and Impact of Influenza 16-18 January 2019, Stockholm

Final Programme here. See Meeting report

The ISIRV Journal, Influenza and other Respiratory Viruses, is now published in an online only format. No printed issue will be produced but authors will still be able to order offprints of their own articles. ISIRV members will receive a 10% discount for articles submitted.

Contact for the code.